Receiving a COVID-19 mRNA vaccine near the start of cancer immunotherapy dramatically improved survival in advanced lung and skin cancer patients. The discovery hints at a new era of universal, immune-boosting cancer vaccines. Credit: Shutterstock People with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of beginning immunotherapy lived considerably longer than those who did not, according to new research. Scientists from the University of Florida and the

Tag-uri: Coronavirus